Compared to control, Ascl1-OE tumor cells showed a 3-fold decrease in oligodendrocyte lineage cell types, with OPCs (4%) decreasing by 10-fold while both NFOL (11%) and MOL (11%) each showed a 6% decrease (Fig. 7d). The gene discussed is ASCL1; the disease is neoplasm.